Abstract
Considering the poor prognosis of pediatric patients with invasive fungal infections due to zygomycosis, we present the case of a female adolescent with acute lymphoblastic leukemia, who successfully completed her chemotherapy despite a disseminated double infection with Aspergillus fumigatus and Absidia corymbifera.
MeSH terms
-
Absidia*
-
Adolescent
-
Antifungal Agents / therapeutic use
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Aspergillus fumigatus*
-
Disease Management
-
Female
-
Humans
-
Immunocompromised Host
-
Mycoses / drug therapy*
-
Mycoses / microbiology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Substances
-
Antifungal Agents
-
Antineoplastic Agents